ArriVent BioPharma (AVBP) Earnings Analysis
ArriVent BioPharma (AVBP) next reports earnings on 2026-08-10, consensus EPS -0.98 USD. Last quarter (2026-05-11) it missed with EPS -0.96 USD vs -0.88 USD est (-9.1%). It has beaten estimates in 4/8 recent quarters (50%). Trailing P/E -8.62.
Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades
When does AVBP next report earnings?
| Next earnings date | 2026-08-10 |
|---|---|
| Consensus EPS estimate | -0.98 USD |
| Revenue estimate | n/a |
AVBP earnings history — beats and misses
| Quarter (report date) | EPS actual | EPS est. | Surprise | Result |
|---|---|---|---|---|
| 2026-05-11 | -0.96 USD | -0.88 USD | -9.1% | Miss |
| 2026-03-05 | -0.78 USD | -0.87 USD | +10.3% | Beat |
| 2025-11-10 | -0.83 USD | -0.78 USD | -6.4% | Miss |
| 2025-08-11 | -0.9 USD | -0.7 USD | -28.6% | Miss |
| 2025-05-12 | -1.9 USD | -0.66 USD | -187.9% | Miss |
| 2025-03-03 | -0.6 USD | -0.78 USD | +23.1% | Beat |
| 2024-11-14 | -0.61 USD | -0.82 USD | +25.6% | Beat |
| 2024-08-14 | -0.65 USD | -0.65 USD | 0% | Beat |
Beat rate: 4/8 (50%) over reported quarters with consensus data.
AVBP valuation and analyst view
| Trailing P/E | -8.62 |
|---|---|
| Trailing EPS | -3.22273 USD |
| Price / book | 4.23 |
| Dividend yield | 0.00% |
| Market cap | 1.40B |
| Analyst consensus | Buy (7 buy / 0 hold / 0 sell) |
| Avg price target | 45 USD |
Related research pages
Frequently asked questions
When is ArriVent BioPharma (AVBP)'s next earnings date?
ArriVent BioPharma is next scheduled to report on 2026-08-10, with a consensus EPS estimate of -0.98 USD.
Did AVBP beat earnings last quarter?
In its 2026-05-11 report, AVBP posted EPS of -0.96 USD versus a -0.88 USD estimate — a miss of 9.1%.
What is AVBP's earnings track record?
Over the last 8 reported quarters with consensus data, AVBP beat estimates 4 times (50%).
What is AVBP's current P/E ratio and EPS?
AVBP trades at a trailing P/E of -8.62 on trailing EPS of -3.222732363860576 USD.
What do analysts rate AVBP?
Analyst consensus is "Buy" across 7 ratings (0 strong buy, 7 buy, 0 hold, 0 sell, 0 strong sell). Average 12-month price target: 45 USD.